Oncolytics Biotech (ONCY) Share-based Compensation (IS) (2009 - 2011)

Oncolytics Biotech (ONCY) has 3 years of Share-based Compensation (IS) data on file, last reported at $43342.0 in Q2 2011.

• On a quarterly basis, Share-based Compensation (IS) rose 1685.09% year-over-year to $43342.0 in Q2 2011; TTM through Jun 2011 was $43342.0, a 1685.09% increase from a year earlier, with the FY2010 full-year figure at $2.9 million, up 619.73% from the prior year.
• Share-based Compensation (IS) for Q2 2011 stood at $43342.0, down from $2.9 million in the prior quarter.
• Over the last five years, Share-based Compensation (IS) for ONCY reached as high as $5.6 million in Q3 2010 and fell as low as $2428.0 in Q2 2010.
• Historically, Share-based Compensation (IS) has averaged $2.1 million across 3 years, with a median of $43342.0 in 2011.
• On a YoY basis, Share-based Compensation (IS) climbed as much as 44534.75% in 2010 and fell as far as 87.97% in 2010.
• Year by year, Share-based Compensation (IS) stood at $4.9 million in 2009, then plunged by 42.04% to $2.9 million in 2010, then slumped by 98.48% to $43342.0 in 2011.
• Per Business Quant data, the three most recent Share-based Compensation (IS) figures were $43342.0 in Q2 2011, $2.9 million in Q4 2010, and $5.6 million in Q3 2010.